RHEIN CONJUGATES, PREPARATION METHOD THEREOF AND THEIR USES IN PRODUCING MEDICINES FOR TREATING DIABETIC NEPHROSIS, INTESTINAL ADHESION AND OSTEOARTHRITIS

(19)

(11)

EP 1 913 940 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	24.04.2019 Bulletin 2019/17

(45)	Mention of the grant of the patent:
	21.11.2018 Bulletin 2018/47

(21)	Application number: 06761393.5

(22)	Date of filing: 10.07.2006

(51)

International Patent Classification (IPC):

A61K 31/122^(2006.01)
C07C 66/02^(2006.01)
A61P 1/00^(2006.01)
A61K 31/133^(2006.01)
A61K 31/197^(2006.01)

A61K 31/192^(2006.01)
A61P 13/12^(2006.01)
A61P 19/02^(2006.01)
A61K 31/198^(2006.01)
A61K 31/4965^(2006.01)

(86)	International application number:
	PCT/CN2006/001634

(87)	International publication number:
	WO 2007/012254 (01.02.2007 Gazette 2007/05)

(54)

RHEIN CONJUGATES, PREPARATION METHOD THEREOF AND THEIR USES IN PRODUCING MEDICINES FOR TREATING DIABETIC NEPHROSIS, INTESTINAL ADHESION AND OSTEOARTHRITIS

RHEIN-KONJUGATE, HERSTELLUNGSVERFAHREN DAFÜR UND IHRE VERWENDUNGEN BEI DER HERSTELLUNG VON MEDIKAMENTEN ZUR BEHANDLUNG VON DIABETISCHER NEPHROSE, DARMADHÄSION UND OSTEOARTHRITIS

CONJUGUES DE RHEIN, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS POUR PREPARER DES MEDICAMENTS PERMETTANT DE TRAITER LA NEPHROPATHIE DIABETIQUE, LES ADHERENCES INTESTINALES ET L'OSTEOARTHRITE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

11.07.2005 CN 200510040963

(43)	Date of publication of application:
	23.04.2008 Bulletin 2008/17

(73)	Proprietor: Cong, Xiaodong
	Gulou District Nanjing Jiangsu 210009 (CN)

(72)	Inventors:
	Cong, Xiaodong Nanjing, Jiangsu 210009 (CN) Lin, Yining Nanjing, Jiangsu 210009 (CN) Cong, Yangzi Nanjing, Jiangsu 211169 (CN) Du, Qing Xining, Qinghai 810007 (CN) Chen, Guoxun Nanjing, Jiangsu 210009 (CN) Wang, Keren Nanjing, Jiangsu 210009 (CN)

(74)	Representative: Kramer Barske Schmidtchen Patentanwälte PartG mbB
	European Patent Attorneys Landsberger Strasse 300 80687 München 80687 München (DE)

(56)

References cited: :

EP-A1- 0 990 441
CN-A- 1 178 669
CN-A- 1 712 041
US-A- 2005 129 781
US-A1- 2004 198 695

CH-A5- 630 885
CN-A- 1 547 468
US-A- 5 864 048
US-A1- 2002 119 950
US-A1- 2005 090 553

DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 31 December 2004 (2004-12-31), TAN, LIXUE ET AL: "Effects of combination therapy of rhein and tetramethylpyrazine on experimental hepatic fibrosis induced by tetrachloride" XP002569919 retrieved from STN Database accession no. 2005:1008639 & ZHONGHUA GANZANGBING ZAZHI ( 2004 ), 12(11), 692-693 CODEN: ZGZZFE; ISSN: 1007-3418, 2004,
DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 7 January 2005 (2005-01-07), SEO, WANG SIK: "Composition for improving adult diseases and obesity using active ingredients of medicinal plants" XP002569920 retrieved from STN Database accession no. 2006:842229 & KR 2005 001 556 A (S. KOREA) 7 January 2005 (2005-01-07)
DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 2004, PEREIRA, A. ACOSTA ET AL: "Diacerein. New therapeutic approach in osteoarthritis" XP002569921 retrieved from STN Database accession no. 2005:220344 & DOLOR ( 2004 ), 19(4), 221-226 CODEN: DOLOFV; ISSN: 0214-0659, 2004,
VERBRUGGEN G: "Chondroprotective drugs in degenerative joint diseases" RHEUMATOLOGY, OXFORD UNIVERSITY PRESS, LONDON, GB, vol. 45, no. 2, 1 February 2006 (2006-02-01), pages 129-138, XP002457796 ISSN: 1462-0324
DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 1988, LENG-PESCHLOW E: "Effect of sennosides and related compounds on intestinal transit in the rat.", Database accession no. NLM3368525 & PHARMACOLOGY 1988, vol. 36 Suppl 1, 1988, pages 40-48, ISSN: 0031-7012

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).